|
1
|
Ulasov I, Borovjagin AV, Kaverina N,
Schroeder B, Shah N, Lin B, Baryshnikov A and Cobbs C: MT1-MMP
silencing by an shRNA-armed glioma-targeted conditionally
replicative adenovirus (CRAd) improves its anti-glioma efficacy in
vitro and in vivo. Cancer Lett. 365:240–250. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gilbert MR, Dignam JJ, Armstrong TS, Wefel
JS, Blumenthal DT, Vogelbaum MA, Colman H, Chakravarti A, Pugh S,
Won M, et al: A randomized trial of bevacizumab for newly diagnosed
glioblastoma. N Engl J Med. 370:699–708. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Westphal M, Ylä-Herttuala S, Martin J,
Warnke P, Menei P, Eckland D, Kinley J, Kay R and Ram Z; ASPECT
Study Group, : Adenovirus-mediated gene therapy with sitimagene
ceradenovec followed by intravenous ganciclovir for patients with
operable high-grade glioma (ASPECT): a randomised, open-label,
phase 3 trial. Lancet Oncol. 14:823–833. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Holland EC: Glioblastoma multiforme: The
terminator. Proc Natl Acad Sci USA. 97:pp. 6242–6244. 2000;
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nemunaitis J and Edelman J: Selectively
replicating viral vectors. Cancer Gene Ther. 9:987–1000. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Geoerger B, Vassal G, Opolon P, Dirven CM,
Morizet J, Laudani L, Grill J, Giaccone G, Vandertop WP, Gerritsen
WR and van Beusechem VW: Oncolytic activity of p53-expressing
conditionally replicative adenovirus AdDelta24-p53 against human
malignant glioma. Cancer Res. 64:5753–5759. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wei F, Wang H, Chen X, Li C and Huang Q:
Dissecting the roles of E1A and E1B in adenoviral replication and
RCAd-enhanced RDAd transduction efficacy on tumor cells. Cancer
Biol Ther. 15:1358–1366. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alemany R, Balagué C and Curiel DT:
Replicative adenoviruses for cancer therapy. Nat Biotechnol.
18:723–727. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
van Beusechem VW, van den Doel PB, Grill
J, Pinedo HM and Gerritsen WR: Conditionally replicative adenovirus
expressing p53 exhibits enhanced oncolytic potency. Cancer Res.
62:6165–6171. 2002.PubMed/NCBI
|
|
10
|
Fukuda K, Abei M, Ugai H, Kawashima R, Seo
E, Wakayama M, Murata T, Endo S, Hamada H, Hyodo I and Yokoyama KK:
E1A, E1B double-restricted replicative adenovirus at low dose
greatly augments tumor-specific suicide gene therapy for
gallbladder cancer. Cancer Gene Ther. 16:126–136. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu J, Mo Y, Wang X, Liu J, Zhang X, Wang
J, Hu L, Yang C, Chen L and Wang Y: Conditionally replicative
adenovirus-based mda-7/IL-24 expression enhances sensitivity of
colon cancer cells to 5-fluorouracil and doxorubicin. J
Gastroenterol. 48:203–213. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chu RL, Post DE, Khuri FR and Van Meir EG:
Use of replicating oncolytic adenoviruses in combination therapy
for cancer. Clin Cancer Res. 10:5299–5312. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chiocca EA: Oncolytic viruses. Nature Rev
Cancer. 2:938–950. 2002. View
Article : Google Scholar
|
|
14
|
Fueyo J, Alemany R, Gomez-Manzano C,
Fuller GN, Khan A, Conrad CA, Liu TJ, Jiang H, Lemoine MG, Suzuki
K, et al: Preclinical characterization of the antiglioma activity
of a tropism-enhanced adenovirus targeted to the retinoblastoma
pathway. J Natl Cancer Inst. 95:652–660. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Geoerger B, Grill J, Opolon P, Morizet J,
Aubert G, Terrier-Lacombe MJ, Bressac De-Paillerets B, Barrois M,
Feunteun J, Kirn DH and Vassal G: Oncolytic activity of the E1B-55
kDa-deleted adenovirus ONYX-015 is independent of cellular p53
status in human malignant glioma xenografts. Cancer Res.
62:764–772. 2002.PubMed/NCBI
|
|
16
|
Lamfers ML, Grill J, Dirven CM, Van
Beusechem VW, Geoerger B, van den Berg J, Alemany R, Fueyo J,
Curiel DT, Vassal G, et al: Potential of the conditionally
replicative adenovirus Ad5-Delta24RGD in the treatment of malignant
gliomas and its enhanced effect with radiotherapy. Cancer Res.
62:5736–5742. 2002.PubMed/NCBI
|
|
17
|
Wirth T, Kuhnel F and Kubicka S:
Telomerase-dependent gene therapy. Curr Mol Med. 5:243–251. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wirth T, Zender L, Schulte B, Mundt B,
Plentz R, Rudolph KL, Manns M, Kubicka S and Kühnel F: A
telomerase-dependent conditionally replicating adenovirus for
selective treatment of cancer. Cancer Res. 63:3181–3188.
2003.PubMed/NCBI
|
|
19
|
Alemany R: Conditionally replicating
adenoviruses for cancer treatment. Cancer Gene Ther. 1–248.
2005.PubMed/NCBI
|
|
20
|
Wilhelmsson U, Eliasson C, Bjerkvig R and
Pekny M: Loss of GFAP expression in high-grade astrocytomas does
not contribute to tumor development or progression. Oncogene.
22:3407–3411. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee K, Jeon K, Kim JM, et al:
Downregulation of GFAP, TSP-1 and p53 in human glioblastoma cell
line, U373MG, by IE1 protein from human cytomegalovirus. Glia.
51:1–12. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tazawa H, Kagawa S and Fujiwara T:
Advances in adenovirus-mediated p53 cancer gene therapy. Expert
Opin Biol Ther. 13:1569–1583. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Heise C, Hermiston T, Johnson L, Brooks G,
Sampson-Johannes A, Williams A, Hawkins L and Kirn D: An adenovirus
E1A mutant that demonstrates potent and selective systemic
anti-tumoral efficacy. Nat Med. 6:1134–1139. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Collins V: Gene amplification in human
gliomas. Glia. 15:289–296. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin T, Wang M, Liang HS and Liu EZ: The
expression of p53, mgmt and egfr in brain glioma and clinical
significance. J Biol Regul Homeost Agents. 29:143–149.
2015.PubMed/NCBI
|
|
26
|
Chen L, Zhang R, Li P, Liu Y, Qin K, Fa
ZQ, Liu YJ, Ke YQ and Jiang XD: p53-induced microRNA-107 inhibits
proliferation of glioma cells and down-regulates the expression of
CDK6 and Notch-2. Neurosci Lett. 534:327–332. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang ZX, Wang D, Wang G, Zhang QH, Liu JM,
Peng P and Liu XH: Clinical study of recombinant adenovirus-p53
combined with fractionated stereotactic radiotherapy for
hepatocellular carcinoma. J Cancer Res Clin Oncol. 136:625–630.
2010. View Article : Google Scholar : PubMed/NCBI
|
